1. Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, andγScintigraphy Imaging
    Javed Ahmad et al, 2014, BioMed Research International CrossRef
  2. Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies
    Victoria M. Steffes et al, 2017, Biomaterials CrossRef
  3. null
    A. Elhissi et al, 2018 CrossRef
  4. Preferential hepatic uptake of paclitaxel-loaded poly-( d - l -lactide- co -glycolide) nanoparticles — A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution
    Dipika Mandal et al, 2018, International Journal of Biological Macromolecules CrossRef
  5. Cardio-Oncology
    Carrie G. Lenneman et al, 2016, Circ Res CrossRef
  6. In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations
    Md. Raihan Chowdhury et al, 2019, International Journal of Pharmaceutics CrossRef
  7. Current status of nanomedicine in the chemotherapy of breast cancer
    A. I. Fraguas-Sánchez et al, 2019, Cancer Chemother Pharmacol CrossRef
  8. Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation
    Ying Lu et al, 2014, Journal of Controlled Release CrossRef
  9. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution
    Yong Xu et al, 2016, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  10. Efficient Drug Delivery of Paclitaxel Glycoside: A Novel Solubility Gradient Encapsulation into Liposomes Coupled with Immunoliposomes Preparation
    Tsukasa Shigehiro et al, 2014, PLoS ONE CrossRef
  11. Preparation, Pharmacokinetics, Biodistribution, Antitumor Efficacy and Safety of Lx2-32c-Containing Liposome
    Hongbo Wang et al, 2014, PLoS ONE CrossRef
  12. Paradoxical rise of hemolytic complement in the blood of mice during zymosan- and liposome-induced CARPA: a pilot study
    Tamás Mészáros et al, 2015 CrossRef
  13. Nanotechnology for the delivery of phytochemicals in cancer therapy
    Jing Xie et al, 2016, Biotechnology Advances CrossRef
  14. Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor
    Jin Cheul Kim et al, 2016, International Journal of Pharmaceutics CrossRef
  15. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan
    Umesh Gupta et al, 2017, International Journal of Biological Macromolecules CrossRef
  16. Self-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapy
    Longbing Ling et al, 2017, International Journal of Pharmaceutics CrossRef
  17. Paclitaxel: What has been done and the challenges remain ahead
    Ezequiel Bernabeu et al, 2017, International Journal of Pharmaceutics CrossRef
  18. null
    Abdelbary M.A. Elhissi et al, 2020 CrossRef
  19. Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer
    Zhao Bi et al, 2020, Breast Cancer Res Treat CrossRef
  20. Paclitaxel-eluting silicone airway stent for preventing granulation tissue growth and lung cancer relapse in central airway pathologies
    Jesse Xu et al, 2020, Expert Opinion on Drug Delivery CrossRef
  21. Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents
    Aleksey M. Chaulin et al, 2020, Russ Open Med J CrossRef
  22. Physicochemical Characterization of PHBV Nanoparticles Functionalized with Multiple Bioactives Designed to be Theranostics for Lung Cancer
    Paula Solar et al, 2020, J Clust Sci CrossRef
  23. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes
    Julia Jiménez-López et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  24. The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
    Peter Hoogevest et al, 2021, Eur. J. Lipid Sci. Technol. CrossRef
  25. Bioactive nanotherapeutic trends to combat triple negative breast cancer
    Pallabita Chowdhury et al, 2021, Bioactive Materials CrossRef
  26. Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
    Silvia Voci et al, 2021, Gels CrossRef
  27. The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions
    Yanlin Gao et al, 2021, Nanoscale CrossRef
  28. Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
    Jun Ye et al, 2021, J Nanobiotechnol CrossRef
  29. Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy
    Vanshikha Singh et al, 2021, European Polymer Journal CrossRef
  30. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases
    Patrycja Paluszkiewicz et al, 2021, IJMS CrossRef
  31. Paclitaxel Drug Delivery Systems: Focus on Nanocrystals’ Surface Modifications
    Razan Haddad et al, 2022, Polymers CrossRef
  32. null
    A.I. Fraguas-Sanchez et al, 2022 CrossRef